Search our Innovation Portfolio

We provide self-management and prevention technology for musculoskeletal (MSK) conditions and Occupational Health.  Organisations integrate getUBetter so that patients can be linked to their local self-management pathways via clinicians, support staff or independently from GP websites 24/7. 

Health Organisations standardise their care, provide bespoke local content, automate referrals, promote self-management, stratify care and reduce costs.  Patients receive personalised and targeted self-management and prevention whilst being automatically connected to their local healthcare provider, treatment and support services. 

getUBetter provides access to multiple MSK conditions from a single app, enabling standardised care to be configured to multiple organisations simultaneously and “on-board” new conditions cost effectively. 

We are currently developing new technology, simplifying integration, improving behaviour change, evaluating and optimising our scalability.

Good Boost creates technology to deliver individually tailored aquatic rehabilitation for musculoskeletal conditions in partnership with local pools. Powered by artificial intelligence, the Good Boost software is delivered on waterproof tablet computers to allow participants to progress in their exercises at their own pace.

This supports the self-management of musculoskeletal conditions through treatment and prevention in a low-impact and low-pain environment. Pool staff and volunteers are trained and provided with our validated and registered medical technology.

Together, this delivers a community service that reduces pain and improves physical function which is locally accessible and affordable (£4-7 average cost per session). With participants completing a digital registration form on induction and repeating outcome measures every 4 weeks, we demonstrate user changes in key MSK metrics over time.  

Mogrify™ has developed a proprietary direct cellular conversion technology, which makes it possible to transform (transmogrify) any mature human cell type into any other without going through a pluripotent stem cell- or progenitor cell-state.

Mogrify is leveraging this technology to identify small molecules capable of converting expandable cell types into chondrocytes in order to create a scalable supply of allogeneic chondrocytes for use in regeneration of the joints in cartilage defects and osteoarthritis.